These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 14161520

  • 1. CLINICAL AND LABORATORY NOTE EEG STUDY OF METHYSERGIDE IN MIGRAINE.
    FELDMAN RG, GLASER GH.
    Electroencephalogr Clin Neurophysiol; 1963 Aug; 15():699-702. PubMed ID: 14161520
    [No Abstract] [Full Text] [Related]

  • 2. USE OF METHYSERGIDE IN THE TREATMENT OF EXTRACRANIAL VASCULAR HEADACHE.
    LOVSHIN LL.
    Headache; 1963 Oct; 3():107-11. PubMed ID: 14094106
    [No Abstract] [Full Text] [Related]

  • 3. THE PROPHYLACTIC EFFECT OF 1-METHYL-D-LYSERGIC ACID BUTANOLAMIDE (METHYSERGIDE) IN THE TREATMENT OF VASCULAR HEADACHE. A CLINICAL STUDY.
    CROWTHER DL.
    Med Exp Int J Exp Med; 1964 Oct; 10():137-43. PubMed ID: 14129849
    [No Abstract] [Full Text] [Related]

  • 4. METHYSERGIDE (SANSERT) IN THE PREVENTION OF MIGRAINE: A CLINICAL TRIAL.
    LLOYD-SMITH DL, MCNAUGHTON FL.
    Can Med Assoc J; 1963 Dec 14; 89(24):1221-3. PubMed ID: 14084702
    [Abstract] [Full Text] [Related]

  • 5. METHYSERGIDE FOR PREVENTION OF HEADACHE; EXPERIENCE IN FIVE HUNDRED PATIENTS OVER THREE YEARS.
    GRAHAM JR.
    N Engl J Med; 1964 Jan 09; 270():67-72. PubMed ID: 14063471
    [No Abstract] [Full Text] [Related]

  • 6. THE OTOLARYNGOLOGIST AND THE COMMON HEADACHE SYNDROMES.
    OSTFELD AM.
    Trans Am Acad Ophthalmol Otolaryngol; 1963 Jan 09; 67():766-9. PubMed ID: 14082486
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. METHYSERGIDE IN THE MIGRAINE SYNDROME.
    SHEKELLE RB, OSTFELD AM.
    Clin Pharmacol Ther; 1964 Jan 09; 5():201-4. PubMed ID: 14155162
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [TREATMENT OF MIGRAINE AND ERYTHROPROSOPALGIA WITH METHYSERGIDE].
    HEYCK H.
    Munch Med Wochenschr; 1964 Nov 27; 106():2213-9. PubMed ID: 14315954
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [PATHOPHYSIOLOGY AND TREATMENT OF MIGRAINE].
    CRAMER H.
    Dtsch Med Wochenschr; 1964 Jan 24; 89():184-5. PubMed ID: 14117080
    [No Abstract] [Full Text] [Related]

  • 14. The serotonin antagonist 1-methyl-D-lysergic acid butanolamine (UML-491) or methysergide ('Deseril'), its pharmacodynamics and effects on 'migraine type' vascular headaches.
    LEIGH WE.
    S Afr Med J; 1963 Jun 15; 37():631-7. PubMed ID: 13929429
    [No Abstract] [Full Text] [Related]

  • 15. [Deseril (methysergide) in the treatment of vascular migraine headache].
    Zec N, Bokonjić R.
    Neuropsihijatrija; 1964 Jun 15; 12(1-4):137-45. PubMed ID: 16305167
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. CLINICAL STUDIES ON THE TREATMENT OF VASCULAR HEADACHES, A PROGRESS REPORT ON METHYSERGIDE (SANSERT).
    ABBOTT KH.
    Headache; 1965 Jan 15; 5():261-71. PubMed ID: 14264174
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.